Cargando…
Management of noninfectious posterior uveitis with intravitreal drug therapy
Uveitis is an important cause of vision loss worldwide due to its sight-threatening complications, especially cystoid macular edema, as well as choroidal neovascularization, macular ischemia, cataract, and glaucoma. Systemic corticosteroids are the mainstay of therapy for noninfectious posterior uve...
Autores principales: | Tan, Hui Yi, Agarwal, Aniruddha, Lee, Cecilia S, Chhablani, Jay, Gupta, Vishali, Khatri, Manoj, Nirmal, Jayabalan, Pavesio, Carlos, Agrawal, Rupesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068474/ https://www.ncbi.nlm.nih.gov/pubmed/27789936 http://dx.doi.org/10.2147/OPTH.S89341 |
Ejemplares similares
-
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant
por: Myung, Jane S, et al.
Publicado: (2010) -
Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021) -
Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011) -
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
por: Sheppard, John D, et al.
Publicado: (2012) -
New pharmacotherapy options for noninfectious posterior uveitis
por: Pleyer, Uwe, et al.
Publicado: (2021)